(Q41735037)

English

Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension

scientific article published on March 1998

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1 reference

Europe PubMed Central

Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

open-angle glaucoma

1 reference

based on heuristic

inferred from title

author name string

Adkins JC

1

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Balfour JA

2

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

225-241

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of ocular pigmentation on intraocular pressure response to timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of brimonidine on aqueous humor dynamics in human eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side Effects of alpha-Adrenergic Agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of topical clonidine on intraocular pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: a review of safety, efficacy, dose response, and dosing studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 1-year study of brimonidine twice daily in glaucoma and ocular hypertension. A controlled, randomized, multicenter clinical trial. Chronic Brimonidine Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term functional outcome after early surgery compared with laser and medicine in open-angle glaucoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Iris pigmentation and atropine mydriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adrenergic and imidazoline receptor-mediated responses to UK-14,304-18 (brimonidine) in rabbits and monkeys. A species difference

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy of brimonidine in decreasing elevations in intraocular pressure after laser trabeculoplasty.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological advances in the treatment of glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of brimonidine concentrations in human plasma by a highly sensitive gas chromatography/mass spectrometric assay

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brimonidine in the prevention of intraocular pressure elevation following argon laser trabeculoplasty

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intraocular pressure and glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Open-angle glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular beta-blockers in glaucoma management. Clinical pharmacological aspects

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with the long-term use of 1% apraclonidine. Incidence of allergic reactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preclinical evaluation of brimonidine

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic effects of medications used to treat glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New developments in the drug treatment of glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroprotection by the alpha 2-adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Corneal and conjunctival/scleral penetration of p-aminoclonidine, AGN 190342, and clonidine in rabbit eyes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Basic and acidic fibroblast growth factors have trophic effects on neurons from multiple CNS regions

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Localization of alpha-2 adrenergic receptors in the human eye

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secondary mechanisms in neuronal trauma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of brimonidine metabolism with rat, rabbit, dog, monkey and human liver fractions and rabbit liver aldehyde oxidase

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of apraclonidine and timolol in chronic open-angle glaucoma. A three-month study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

UK-14,304, a potent and selective α2-agonist for the characterisation of α-adrenoceptor subtypes

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of brimonidine 0.5% on intraocular pressure spikes following 360% argon laser trabeculoplasty. The Brimonidine-ALT Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure. The Brimonidine Study Group III

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brimonidine tartrate: a one-month dose response study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of glaucoma. The Beaver Dam Eye Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-18) in cats, rabbits and monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective alpha 2-adrenergic agonists B-HT 920 and UK14304-18. Effects on aqueous humor dynamics in monkeys

1 reference

https://pubmed.ncbi.nlm.nih.gov/9534022

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2165/00002512-199812030-00005

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41735037&oldid=2204748047"